Bausch Health Companies | VRX - Betriebsaufwand

Aktienkurs
7.69
Täglich Wechseln
0.10 1.32%
Monatlich
9.54%
Jährlich
2.12%
Q2 Prognose
7.53




Betriebsaufwand Veränderung Datum
Amgen USD 5.9B 773M 2025-12
ANI Pharmaceuticals USD 217.93M 287.88M 2025-12
Aurora Cannabis CAD 129.98M 16.05M 2025-12
Bausch Health Companies USD 2.08B 113M 2025-12
Biogen USD 1.88B 81.4M 2025-09
Bristol-Myers Squibb USD 8.3B 10.25B 2025-12
Canopy Growth CAD 87.2M 6.22M 2025-12
Corcept Therapeutics USD 197.64M 219K 2025-12
Danaher USD 52.95B 47.61B 2026-03
Drreddys Laboratories INR 72.94B 4.33B 2025-12
Eli Lilly USD 10.31B 1.09B 2025-12
Gilead Sciences USD 4.96B 707M 2025-12
Nektar Therapeutics USD 40.9M 44.19M 2025-12
Novo Nordisk DKK 46.76B 3.99B 2025-12
Pacira USD 193.68M 27.32M 2025-12
Perrigo USD 1.03B 75.3M 2025-12
Phibro Animal Health USD 332.36M 20.68M 2025-12
Prestige Brands USD 200.95M 6.51M 2025-12
Supernus Pharmaceuticals USD 197.75M 54.54M 2025-12
Vertex Pharmaceuticals USD 1.93B 89.1M 2025-12
Zoetis USD 1.55B 3.85B 2025-12